Premier Anti-Aging Co., Ltd. revised consolidated earnings guidance for the fiscal year ending July 31, 2024. For the full year ending July 31, 2024, the company expected net sales of JPY 20,000 million, operating loss of JPY 1,000 million, loss attributable to owners of parent of JPY 2,500 million and basic loss per share of JPY 286.68 compared to previously expected net sales of JPY 26,000 million, operating profit of JPY 100 million, profit attributable to owners of parent of JPY 200 million and basic earnings per share of JPY 22.93.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
790 JPY | -1.13% | +6.47% | -21.86% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.86% | 43.76M | |
-3.33% | 249B | |
+10.09% | 18.86B | |
0.00% | 17.37B | |
-1.32% | 10.65B | |
-7.73% | 10.26B | |
+3.86% | 6.72B | |
+9.76% | 5.94B | |
-0.06% | 4.55B | |
-16.98% | 3.83B |
- Stock Market
- Equities
- 4934 Stock
- News Premier Anti-Aging Co., Ltd.
- Premier Anti-Aging Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending July 31, 2024